Trial Outcomes & Findings for Implantable Cardioverter-Defibrillator Use in the VA System (NCT NCT01217827)

NCT ID: NCT01217827

Last Updated: 2021-05-19

Results Overview

Referral of the patient to electrophysiology clinic for evaluation for cardioverter defibrillator implantation.

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

89 participants

Primary outcome timeframe

6 months

Results posted on

2021-05-19

Participant Flow

Participant milestones

Participant milestones
Measure
Clinical Reminder
Reminder of potential candidacy for an implantable cardioverter defibrillator. The reminder is placed in the medical record with copy to the primary provider and any cardiologist managing the patient. Clinical Reminder
Control
This group does not receive an intervention.
Overall Study
STARTED
46
43
Overall Study
COMPLETED
46
43
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Implantable Cardioverter-Defibrillator Use in the VA System

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Clinical Reminder
n=46 Participants
Reminder of potential candidacy for an implantable cardioverter defibrillator. The reminder is placed in the medical record with copy to the primary provider and any cardiologist managing the patient. Clinical Reminder
Control
n=43 Participants
This group does not receive an intervention.
Total
n=89 Participants
Total of all reporting groups
Age, Continuous
66 years
STANDARD_DEVIATION 8 • n=5 Participants
64 years
STANDARD_DEVIATION 8 • n=7 Participants
65 years
STANDARD_DEVIATION 8 • n=5 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
0 Participants
n=7 Participants
3 Participants
n=5 Participants
Sex: Female, Male
Male
43 Participants
n=5 Participants
43 Participants
n=7 Participants
86 Participants
n=5 Participants
Region of Enrollment
United States
46 participants
n=5 Participants
43 participants
n=7 Participants
89 participants
n=5 Participants

PRIMARY outcome

Timeframe: 6 months

Referral of the patient to electrophysiology clinic for evaluation for cardioverter defibrillator implantation.

Outcome measures

Outcome measures
Measure
Clinical Reminder
n=46 Participants
Reminder of potential candidacy for an implantable cardioverter defibrillator. The reminder is placed in the medical record with copy to the primary provider and any cardiologist managing the patient. Clinical Reminder
Control
n=43 Participants
This group does not receive an intervention.
Referral for Implantable Cardioverter Defibrillator
11 participants
1 participants

Adverse Events

Clinical Reminder

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 4 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Clinical Reminder
n=46 participants at risk
Reminder of potential candidacy for an implantable cardioverter defibrillator. The reminder is placed in the medical record with copy to the primary provider and any cardiologist managing the patient. Clinical Reminder
Control
n=43 participants at risk
This group does not receive an intervention.
Cardiac disorders
Death
2.2%
1/46 • Number of events 1
9.3%
4/43 • Number of events 4

Other adverse events

Adverse event data not reported

Additional Information

Paul Heidenreich

VA Palo Alto HCS

Phone: 650-849-1205

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place